Modeling phenotypes of malignant gliomas

被引:15
|
作者
Sampetrean, Oltea [1 ]
Saya, Hideyuki [1 ]
机构
[1] Keio Univ, Sch Med, Inst Adv Med Res, Div Gene Regulat,Shinjuku Ku, Keio, Japan
关键词
experimental model; genetically engineered mouse model; glioma cell of origin; glioma invasion; malignant glioma; GROWTH-FACTOR RECEPTOR; NEURAL STEM-CELL; MOSAIC ANALYSIS; DOUBLE MARKERS; MOUSE MODELS; BRAIN-TUMORS; GLIOBLASTOMA; ACTIVATION; MIGRATION; INVASION;
D O I
10.1111/cas.13351
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Malignant gliomas are primary tumors of the central nervous system characterized by diffuse infiltration into the brain and a high recurrence rate. Advances in comprehensive genomic studies have provided unprecedented insight into the genetic and molecular heterogeneity of these tumors and refined our understanding of their evolution from low to high grade. However, similar levels of phenotypic characterization are indispensable to understanding the complexity of malignant gliomas. Experimental glioma models have also achieved great progress in recent years. Advances in transgenic technologies and cell culture have allowed the establishment of mouse models that mirror the human disease with increasing fidelity and which support single-cell resolution for phenotypic analyses. Here we review the major types of preclinical glioma models, with an emphasis on how recent developments in experimental modeling have shed new light on two fundamental aspects of glioma phenotype, their cell of origin and their invasive potential.
引用
收藏
页码:6 / 14
页数:9
相关论文
共 50 条
  • [21] Microsurgery for Malignant Gliomas
    M. Gazi Yaşargil
    Paulo A.S. Kadri
    Dianne C.H. Yaşargil
    Journal of Neuro-Oncology, 2004, 69 : 67 - 81
  • [22] Microsurgery for malignant gliomas
    Yasargil, MG
    Kadri, PAS
    Yasargil, DCH
    JOURNAL OF NEURO-ONCOLOGY, 2004, 69 (1-3) : 67 - 81
  • [23] The treatment of malignant gliomas
    Gilbert M.R.
    Loghin M.
    Current Treatment Options in Neurology, 2005, 7 (4) : 293 - 303
  • [24] MANAGEMENT OF MALIGNANT GLIOMAS
    KORNBLITH, PL
    NEUROSURGERY QUARTERLY, 1991, 1 (02) : 97 - 110
  • [25] Chemotherapy for malignant gliomas
    Marosi C.
    Wiener Medizinische Wochenschrift, 2006, 156 (11-12) : 346 - 350
  • [26] Gene therapy: Approaches for the treatment of malignant gliomas
    Schackert, G
    Frank, S
    Schackert, HK
    ONKOLOGIE, 1996, 19 (01): : 16 - 22
  • [27] Steroid requirements during radiotherapy for malignant gliomas
    Marantidou, Athina
    Levy, Christine
    Duquesne, Alyette
    Ursu, Renata
    Bailon, Olivier
    Coman, Irene
    Belin, Catherine
    Carpentier, Antoine F.
    JOURNAL OF NEURO-ONCOLOGY, 2010, 100 (01) : 89 - 94
  • [28] Malignant gliomas.
    Burton E.C.
    Prados M.D.
    Current Treatment Options in Oncology, 2000, 1 (5) : 459 - 468
  • [29] Adoptive cellular immunotherapy for the treatment of malignant gliomas
    Hayes, RL
    Arbit, E
    Odaimi, M
    Pannullo, S
    Scheff, R
    Kravchinskiy, D
    Zaroulis, C
    CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY, 2001, 39 (1-2) : 31 - 42
  • [30] Passive Immunotherapeutic Strategies for the Treatment of Malignant Gliomas
    Nagasawa, Daniel T.
    Fong, Christina
    Yew, Andrew
    Spasic, Marko
    Garcia, Heather M.
    Kruse, Carol A.
    Yang, Isaac
    NEUROSURGERY CLINICS OF NORTH AMERICA, 2012, 23 (03) : 481 - +